General MedicationsORALGeneric

QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE

Standard Dose

12.5MG;EQ 10MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 201356 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE Form and strength TABLET;ORAL - 12.5MG;EQ 10MG BASE Sponsor INVAGEN PHARMS Submission history Latest submission status date: 2022-05-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 201356 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE Form and strength TABLET;ORAL - 12.5MG;EQ 10MG BASE Sponsor INVAGEN PHARMS Submission history Latest submission status date: 2022-05-25 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.